## 



## 





## 



## 





## 

## 




## 



## 







## 

## 

## 


## 



## 








## 


## 

## 

## 

## 





## 

## 

## 




## 

## 

## 


## 



## 

|**QUALIFICATION**|**COMPLETERS**|**ENROLMENTS**|
|---|---|---|
|**Qualification in Educational Psychology (Scotland) (Stage 2)**|**45**|**20**|
|**Qualification in Occupational Psychology (Stage 2)**|**11**|**50**|
|**Qualification in Counselling Psychology**|**3**|**0**|
|**Qualification in Forensic Psychology (Stage 2)**|**45**|**39**|
|**Qualification in Sport and Exercise Psychology (Stage 2)**|**6**|**16**|
|**Qualification in Health Psychology (Stage 2)**|**17**|**17**|
|**Qualification in Clinical Neuropsychology**|**2**|**1**|



## 






## 

## 

## 




## 






## 

## 




## 

## 












## 






## 





## 









## 





## 


## 












## 

## 

## 


## 

## 



## 



## 


## 



## 

## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 




## 

## 

## 

## 

## 

## 



## 

## 



- Making enquiries of the trustees and management on whether they had knowledge of any actual, suspected or alleged fraud; 

- Gaining an understanding of the internal controls established to mitigate risks related to fraud; 

Forvis Mazars **LLP** is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under Section 1212 of the Companies Act 2006. 

- Discussing amongst the engagement team the risks of fraud; and 

- Addressing the risks of fraud through management override of controls by performing journal entry testing. 

There are inherent limitations in the audit procedures described above and the primary responsibility for the prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at 

www.frc.org.u k/auditorsresponsibilities. This description forms part of our auditor's report. 

## **USE OF THE AUDIT REPORT** 

This report is made solely to the charity's trustees as a body in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008 and Regulation 10 of the Charities Accounts (Scotland) Regulations 2006. Our audit work has been undertaken so that we might state to the charity's trustees those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity's trustees as a body for our audit work, for this report, or for the opinions we have formed. 


Forvis Mazars **LLP,** Statutory Auditor Chartered Accountants and Statutory Auditor Two Chamberlain Square, Birmingham, B3 3AX 

Date **11 - 08 - 2025** 

BPS ANNUAL REPORT 2024 • GROUP FINANCIAL STATEMENTS 2024 • 

Doc ID: 00b2a01fb6c68705bac4ecdd343d0060d6f176fb 



## 

|||**2024**|**2024**|**2024**|**2024**|**2023**|
|---|---|---|---|---|---|---|
|||**Unrestricted**|**Designated**|**Restricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|||
|**Income:**|**Note**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Income from charitable activities:**|||||||
|Subscriptions||7,613|–|–|7,613|6,603|
|Registers and directories||524|–|–|524|560|
|Conferences and events||683|–|–|683|922|
|Journals and book publishing|4|1,694|–|–|1,694|2,200|
|Other income|5|2,340|–|–|2,340|2,215|
|**Income from Trading operations**|7|492|–|–|492|524|
|**Investment income**|6|44|–|–|44|13|
|**Total Income**||13,390|–|–|13,390|13,037|
|**Expenditure:**|||||||
|**Expenditure on raising funds:**|||||||
|Trading costs|7|324|–|–|324|461|
|Expenditure on charitable activities before||12,295|–|–|12,295|13,867|
|fundamental restructuring costs|||||||
|Fundamental restructuring costs||–|–|–|–|431|
|**Expenditure on charitable activities**||12,295|–|–|12,295|14,298|
|**Other expenditure: **Change programme & Black||45|–|–|45|56|
|and Asian Fund|||||||
|**Total expenditure**||12,664|–|–|12,664|14,815|
|(Loss)/gains on investments|13|659|–|–|659|1,363|
|Net gain before fundamental restructuring costs||1,385|–|–|1,385|16|
|Fundamental restructuring costs||–|–|–|–|(431)|
|**Net (loss)/gain**||1,385|–|–|1,385|(415)|
|**Transfer between funds**|17|42|(40)|(2)|–|–|
|**Net movement in funds**||1,427|(40)|(2)|1,385|(415)|
|**Reconciliation of funds**|||||||
|Total funds brought forward||15,534|175|58|15,767|16,182|
|**Total funds carried forward**||16,961|135|56|17,152|15,767|





|||**2024**|**2024**|**2024**|**2024**|**2023**|
|---|---|---|---|---|---|---|
|||**Unrestricted**|**Designated**|**Restricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|||
|**Income:**|**Note**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Income from charitable activities:**|||||||
|Subscriptions||7,613|–|–|7,613|6,603|
|Registers and directories||524|–|–|524|560|
|Conferences and events||683|–|–|683|922|
|Journals and book publishing|4|1,694|–|–|1,694|2,200|
|Other income|5|2,340|–|–|2,340|2,215|
|**Income from Trading operations**|7|300|–|–|300|28|
|**Investment income**|6|44|–|–|44|13|
|**Total Income**||13,198|–|–|13,198|12,541|
|**Expenditure:**|||||||
|Expenditure on charitable activities before||12,295|–|–|12,295|13,867|
|fundamental restructuring costs|||||||
|Fundamental restructuring costs||–|–|–|–|431|
|**Expenditure on charitable activities**||12,295|–|–|12,295|14,298|
|**Other expenditure: **Change programme||45|–|–|45|56|
|& Black and Asian Fund|||||||
|**Total expenditure**||12,340|–|–|12,340|14,354|
|(Loss)/gains on investments|13|659|–|–|659|1,363|
|Net gain before fundamental restructuring||1,517|–|–|1,517|(19)|
|costs|||||||
|Fundamental restructuring costs||–|–|–|–|(431)|
|**Net (loss)**||1,517|–|–|1,517|(450)|
|**Transfer between funds**|17|42|(40)|(2)|–|–|
|**Net movement in funds**||1,559|(40)|(2)|1,517|(450)|
|**Reconciliation of funds**|||||||
|Total funds brought forward||15,402|175|58|15,635|16,085|
|**Total funds carried forward**||16,961|135|56|17,152|15,635|





|||**2024**|**2023**|
|---|---|---|---|
||**Note**|**£'000**|**£'000**|
|**Fixed assets**||||
|Tangible assets|12|6,902|7,080|
|Investments|13|12,241|11,582|
|**Total fixed assets**||19,143|18,662|
|**Current assets**||||
|Debtors|14|1,604|1,212|
|Cash at bank and in hand||1,049|828|
|||2,653|2,040|
|**Liabilities**||||
|Creditors: amounts falling due within|15|(4,269)|(4,504)|
|one year||||
|**Net current liabilities**||(1,616)|(2,464)|
|Provisions|16|(375)|(431)|
|**Net assets**||17,152|15,767|
|**The funds of the group:**||||
|Restricted income funds|17|56|58|
|**Unrestricted funds:**|17|||
|General funds||12,962|11,520|
|Designated funds||135|175|
|Revaluation reserve||3,999|4,014|
|**Total unrestricted funds**|17|17,096|15,709|
|**Total funds**||17,152|15,767|






|||**2024**|**2023**|
|---|---|---|---|
||**Note**|**£'000**|**£'000**|
|**Fixed assets**||||
|Tangible assets|12|6,902|7,080|
|Investments|13|12,241|11,582|
|**Total fixed assets**||19,143|18,662|
|**Current assets**||||
|Debtors|14|1,755|1,268|
|Cash at bank and in hand||863|553|
|||2,618|1,821|
|**Liabilities**||||
|Creditors: amounts falling due|15|(4,234)|(4,417)|
|within one year||||
|**Net current liabilities**||(1,616)|(2,596)|
|Provisions|16|(375)|(431)|
|**Net assets**||17,152|15,635|
|**The funds of the society:**||||
|Restricted income funds|17|56|58|
|**Unrestricted funds:**|17|||
|General funds||12,962|11,388|
|Designated funds||135|175|
|Revaluation reserve||3,999|4,014|
|**Total unrestricted funds**|17|17,096|15,577|
|**Total funds**||17,152|15,635|






## 

|||**Group**|**Group**|**Society**|**Society**|
|---|---|---|---|---|---|
|||**2024**|**2023**|**2024**|**2023**|
||**Note**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Net Cash provided by**|22|213|(557)|302|(660)|
|**operating activities**||||||
|Cash flow from investing||||||
|activities:||||||
|Dividend and interest from||44|13|44|13|
|investments||||||
|Purchase of tangible fixed assets||(36)|(15)|(36)|(15)|
|Disposal of tangible fixed assets||–|–|–|–|
|Proceeds from sales of||–|–|–|–|
|investments||||||
|**Net Cash Provided by investing**||8|(2)|8|(2)|
|**activities**||||||
|**Net cash from/(used) in**||||||
|**Financial activities**||||||
|Repayments of borrowing||–|–|–|–|
|**Net cash provided by (used in)**||–|–|–|–|
|**financing activities**||||||
|**Change in cash and cash**||221|(559)|310|(662)|
|**equivalents in the year**||||||
|**Cash and cash equivalents at**||828|1,387|553|1,215|
|**the beginning of the year**||||||
|**Cash and cash equivalents at**||1,049|828|863|553|
|**the end of the year**||||||





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 



## 

||**2024**|**2023**|
|---|---|---|
||**£'000**|**£'000**|
|Income from journal subscriptions and sales|1,680|2,181|
|Income from book and publications sales|14|19|
||1,694|2,200|
|**5. OTHER INCOME**|||
||**2024**|**2023**|
||**£'000**|**£'000**|
|Advertising revenue|193|201|
|Examination income|786|824|
|Quality assurance|1,018|843|
|Rental income|32|29|
|Professional Development Centre|306|311|
|Sundry income|5|7|
||2,340|2,215|



## 

||**2024**|**2023**|
|---|---|---|
||**£'000**|**£'000**|
|Income from listed investments|44|13|
||44|13|





## 

## 

||**2024**|**2023**|
|---|---|---|
||**£'000**|**£'000**|
|Turnover|289|402|
|Cost of sales|(98)|(168)|
|Gross profit|191|234|
|Distribution costs|(106)|(85)|
|Administrative costs|(46)|(83)|
|Profit/(Loss) before taxation|39|66|
|Taxation|–|–|
|Profit/(Loss) for year|39|66|
|The assets and liabilities of the subsidiary are:|||
||**2024**|**2023**|
||**£'000**|**£'000**|
|Current assets:|||
|Debtors|81|97|
|Cash at bank|42|151|
||123|248|
|Creditors: amount falling within one year|(123)|(248)|
||–|–|





## 

## 

||**2024**|**2023**|
|---|---|---|
||**£'000**|**£'000**|
|Turnover|203|191|
|Cost of sales|(65)|(58)|
|Gross profit|138|133|
|Administrative costs|(38)|(67)|
|Profit/(Loss) before taxation|100|66|
|Taxation|–|–|
|Profit/(Loss)for year|100|66|





|The assets and liabilities of the subsidiary are:|||
|---|---|---|
||**2024**|**2023**|
||**£'000**|**£'000**|
|Current assets:|||
|Debtors|2|–|
|Cash at bank|144|124|
||146|124|
|Creditors: amount falling within one year|(146)|(124)|





## 

||**Property**|**IT**|**HR &**|**Directorate**|||
|---|---|---|---|---|---|---|
||**costs**|**costs**|**Finance**|**costs**|**2024**|**2023**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Charitable expenditure:**|||||||
|Advancement of psychology|53|118|106|14|291|344|
|Application of psychology|4|8|7|1|20|23|
|Conferences and events|9|19|17|2|47|56|
|Co-operation|11|25|23|3|62|74|
|Diffusion of knowledge|86|193|173|22|474|561|
|Examinations and training|43|97|87|11|238|281|
|Membership|100|224|201|26|551|653|
|Science and policy|39|88|79|10|216|257|
|**Total expenditure**|345|772|693|89|1,899|2,249|



## 




## 

||**2024**|**2023**|**2024**|**2023**|
|---|---|---|---|---|
||**Full time**|**Full time**|**Part time**|**Part time**|
|Leicester office|95|106|13|17|
|London office|16|15|2|2|
|Regional centres|–|–|–|–|
|Remote|2|1|5|5|
||113|122|20|24|



||**2024**|**2023**|
|---|---|---|
||**Total**|**Total**|
||**£’000**|**£’000**|
|Gross wages and salaries|5,785|6,455|
|Employer's National Insurance|628|678|
|Defined contribution pension costs|533|577|
|Redundancy costs|181|431|
|Payment in Lieu of notice|99|52|
||7,226|8,193|





## 

||**2024**|**2023**|
|---|---|---|
||**£’000**|**£’000**|
|Payment in Lieu of notice|99|52|
|Settlement agreement|–|–|
|Redundancy|181|431|
|Total|280|483|



||**2024**|**2023**|
|---|---|---|
||**Number**|**Number**|
|£60,000–£69,999|5|7|
|£70,000–£79,999|2|2|
|£80,000–£89,999|1|2|
|£90,000–£99,999|–|–|
|£100,000–£109,999|1|1|
|£110,000–£119,999|1|1|
|£120,000–£129,999|–|–|
|£130,000–£139,999|–|1|
|£140,000–£149,999|1|1|
|£150,000–£159,999|1|–|





## 

||**2024**|**2023**|
|---|---|---|
||**£**|**£**|
|Former President (Dr N. Hayes)|£12,309|£11,000|





## 

||**Freehold**|**Computer**|**Office**|**Total**|
|---|---|---|---|---|
||**land &**|**& Print**|**equipment**||
|**Group and Society**|**buildings**||||
||**£'000**|**£'000**|**£'000**|**£'000**|
|**Cost**|||||
|At 1 January 2024|9,260|240|428|9,928|
|Additions|–|36|–|36|
|Disposals|–|–|–|–|
|At 31 December 2024|9,260|276|428|9,964|
|**Depreciation**|||||
|At 1 January 2024|2,314|222|312|2,848|
|Charge for the year|151|20|44|214|
|Disposals|–|–|–|–|
|At 31 December 2024|2,465|242|356|3,062|
|**Net book value**|||||
|At 31 December 2024|**6,795**|**34**|**72**|**6,902**|
|At 31 December 2023|**6,946**|**18**|**116**|**7,080**|





## 

|**Group and Society**|**2024**|**2023**|
|---|---|---|
||**£'000**|**£'000**|
|Market value at 1 January 2024|11,582|10,219|
|Additions|–|–|
|Disposal proceeds|–|–|
|Net investment (loss)/gain unrealised|659|1,363|
|Net investment (loss)/gain realised|–|–|
|Market value at 31 December 2024|12,241|11,582|
|Cash awaiting investment|–|–|
|**Total at 31 December 2024**|12,241|11,582|



|• Overseas Equities|63.51%|
|---|---|
|• UK Equities|8.31%|
|• Infrastructure & Operating Assets|8.46%|
|• Cash & Near Cash|2.39%|
|• Fixed Interest|7.83%|
|• Property|3.80%|
|• Contractual, Private Equity & Other|5.69%|
|• Derivatives|0.01%|





## 

||**2024**|**2023**|**2024**|**2023**|
|---|---|---|---|---|
||**Group**|**Group**|**Society**|**Society**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|Trade debtors|381|355|312|127|
|Prepayments and accrued income|1,201|795|1,201|795|
|Amounts due from subsidiary|–|–|221|284|
|companies|||||
|VAT recoverable|22|62|22|62|
||1,604|1,212|1,755|1,268|



## 

||**2024**|**2023**|**2024**|**2023**|
|---|---|---|---|---|
||**Group**|**Group**|**Society**|**Society**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|Trade creditors|268|298|255|279|
|Subscriptions received in advance|1,627|1,564|1,627|1,564|
|Other deferred income|1,529|1,574|1,500|1,528|
|Other creditors|134|73|134|73|
|Accruals|535|748|529|723|
|Amounts due to subsidiary companies|–|–|13|3|
|Other taxation and social security|175|247|175|247|
||4,269|4,504|4,234|4,417|
|**Group and Society Deferred Income**|**Group**|**Society**|||
||**£'000**|**£'000**|||
|Balance as at 1 January 2024|3,138|3,091|||
|Amounts released from previous year|(2,085)|(2,039)|||
|Income deferred in the year|2,103|2,075|||
|**Balance as at 31 December 2024**|3,156|3,127|||





## 

## 

||**At 1 Jan 2024**|**Additions**|**Utilised**|**Released**|**At 31 Dec 2024**|
|---|---|---|---|---|---|
||**£’000**||||**£’000**|
|Redundancy|431|–|431|–|–|
|HMRC Voluntary|–|375|–|–|375|
|Disclosure||||||
|Total Provisions|431|375|431|–|375|





## 

## 

||**Funds**<br>**brought**<br>**forward**<br>**at 1 Jan**<br>**2024**|**Income**|**Expenditure**|**Gains Losses**|**Transfers**|**Funds**<br>**carried**<br>**forward**<br>**at 31**<br>**Dec**<br>**2024**|
|---|---|---|---|---|---|---|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|11,520|13,390|(12,664)|659|57|12,962|
|Designated fund|175|–|–|–|(40)|135|
|Revaluation reserve|4,014|–|–|–|(15)|3,999|
|Restricted fund|58|–|–|–|(2)|56|
||15,767|13,390|(12,664)|659|–|17,152|



||**Funds**<br>**brought**<br>**forward**<br>**at 1 Jan**<br>**2024**|**Income**|**Expenditure**|**Gains Losses**|**Transfers**|**Funds**<br>**carried**<br>**forward**<br>**at 31**<br>**Dec**<br>**2024**|
|---|---|---|---|---|---|---|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|11,388|13,198|(12,340)|659|57|12,962|
|Designated fund|175|–|–|–|(40)|135|
|Revaluation reserve|4,014|–|–|–|(15)|3,999|
|Restricted fund|58|–|–|–|(2)|56|
||15,635|13,198|(12,340)|659|–|17,152|





## 

||**Funds**<br>**brought**<br>**forward**<br>**at 1 Jan**<br>**2023**|**Income**|**Expenditure**|**Gains,**<br>**(losses)**|**Transfers**|**Funds**<br>**carried**<br>**forward**<br>**at 31**<br>**Dec**<br>**2023**|
|---|---|---|---|---|---|---|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|11,522|13,037|(14,815)|1,363|413|11,520|
|Designated fund|573|–|–|–|(398)|175|
|Revaluation reserve|4,029|–|–|–|(15)|4,014|
|Restricted fund|58|–|–|–|–|58|
||16,182|13,037|(14,815)|1,363|–|15,767|
|**Society**|||||||
||**Funds**<br>**brought**<br>**forward**<br>**at 1 Jan**<br>**2023**|**Income**|**Expenditure**|**Gains,**<br>**(losses)**|**Transfers**|**Funds**<br>**carried**<br>**forward**<br>**at 31**<br>**Dec**<br>**2023**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|11,425|12,541|(14,354)|1,363|413|11,388|
|Designated fund|573|–|–|–|(398)|175|
|Revaluation reserve|4,029|–|–|–|(15)|4,014|
|Restricted fund|58|–|–|–|–|58|
||16,085|12,541|(14,354)|1,363|–|15,635|



## 

## 



## 

||**Funds**<br>**brought**<br>**forward**<br>**at 1 Jan**<br>**2024**|**Income**|**Expenditure**|**Gains and**<br>**losses**|**Funds**<br>**carried**<br>**forward**<br>**at 31**<br>**Dec**<br>**2024**|
|---|---|---|---|---|---|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|William Inman|7|–|(2)|–|5|
|Visual archive|10|–|–|–|10|
|BJEP fund|41|–|–|–|41|
||58|–|(2)|–|56|
||**Funds**<br>**brought**<br>**forward**<br>**at 1 Jan**<br>**2023**|**Income**|**Expenditure**|**Gains and**<br>**losses**|**Funds**<br>**carried**<br>**forward**<br>**at 31**<br>**Dec**<br>**2023**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|William Inman|7|–|–|–|7|
|Visual archive|10|–|–|–|10|
|BJEP fund|41|–|–|–|41|
||58|–|–|–|58|





## 

||**2024**|**2023**|**2024**|**2023**|
|---|---|---|---|---|
||**Group**|**Group**|**Society**|**Society**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|**Financial assets**|||||
|Debt instruments measured at|403|345|554|435|
|amortised cost|||||
|Instruments measured at fair value|12,241|11,582|12,241|11,582|
|through profit or loss|||||
|**Total net assets**|12,644|11,927|12,795|12,017|
|**Financial liabilities**|||||
|Debt instruments measured at|577|618|577|603|
|amortised cost|||||
|Instruments measured at fair value|–|–|–|–|
|through profit and loss|||||
||577|618|577|603|



## 

||**Unrestricted**|**Restricted**|**Total**||
|---|---|---|---|---|
||**£'000**|**£'000**||**£'000**|
|Tangible fixed assets|6,902|–||6,902|
|Investments|12,241|–||12.241|
|Current assets|2,597|56||2,653|
|Current liabilities|(4,644)|–||(4,644)|
|**Total net assets**|17,096|56||17,152|





## 

## 

||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|6,902|–|6,902|
|Investments|12,241|–|12,241|
|Current assets|2,562|56|2,618|
|Current liabilities|(4,609)|–|(4,609)|
|**Total net assets**|17,096|56|17,152|



||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|7,080|–|7,080|
|Investments|11,582|–|11,582|
|Current assets|1,982|58|2,040|
|Current liabilities|(4,935)|–|(4,935)|
|**Total net assets**|15,709|58|15,767|



||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|7,080|–|7,080|
|Investments|11,582|–|11,582|
|Current assets|1,763|58|1,821|
|Current liabilities|(4,848)|–|(4,848)|
|**Total net assets**|15,577|58|15,635|





## 

## 

|**Divisions**|**Income**|**Expenditure**|
|---|---|---|
|Academics, Researchers and Teachers|28,588|21,059|
|Clinical|460,047|324,509|
|Coaching|74,538|55,128|
|Counselling|150,206|59,613|
|Educational and Child|111,842|103,085|
|Forensic|154,195|149,184|
|Health|104,638|99,066|
|Neuropsychology|66,169|25,696|
|Occupational|146,923|56,003|
|Sport and Exercise|69,040|72,742|
|Educational (Scottish)|16,757|13,346|
|**Sections**|||
|Cognitive|24,303|23,019|
|Community|4,096|1,574|
|Consciousness and Experiential|5,561|6,377|
|Crisis, Disaster and Trauma|14,507|8,050|
|Cyberpsychology|16,434|4,176|
|Defence and Security|2,523|1,319|
|Developmental|36,120|22,956|
|Historical, Philosophical and Theoretical|2,643|1,364|
|Male|6,787|5,844|





## 

|**Sections (continued)**|**Income**|**Expenditure**|
|---|---|---|
|Mathematical, Statistical and Computing|1,445|190|
|Political|1,297|618|
|Psychobiology|5,606|10,201|
|Education|37,031|36,995|
|Sexualities|4,872|953|
|Women and Equalities|21,313|20,010|
|Psychotherapy|17,702|10,256|
|Qualitative Methods|7,987|5,605|
|Social|26,322|19,874|
|Transpersonal|3,437|2,432|
|**Special Groups**|||
|Independent Practitioners|14,667|3,760|
|Social Care|6,340|8,835|
|**DCP Faculties**|||
|Addictions|14,071|13,186|
|Children, Young People and Families|27,818|8,572|
|Clinical Health Psychology|7,167|2,914|
|Eating Disorders|5,392|2,727|
|Forensic Clinical Psychology|8,345|3,484|
|HIV & Sexual Health|1,236|607|
|Holistic Psychology|2,213|2,003|
|Leadership and Management|15,053|10,367|
|Intellectual Disabilities|22,331|12,342|
|Oncology and Palliative Care|2,167|559|





## 

## 

|**DCP Faculties (continued)**|**Income**|**Expenditure**|
|---|---|---|
|Perinatal Psychology|4,773|9,868|
|Psychosis & Complex Mental Health|12,632|5,437|
|Psychology of Older People|25,895|15,694|
|**Total**|**1,793,029**|**1,261,599**|



||**Members**|**£’000**|
|---|---|---|
|Clinical|29|121,694|
|Counselling|2|5,625|
|Educational and Child|4|13,750|
|Health|1|3,750|
|Forensic|2|11,250|





## 

||**Group**|**Group**|**Society**|**Society**|
|---|---|---|---|---|
||**2024**|**2023**|**2024**|**2023**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|Net (outgoing)/incoming resources|1,385|(415)|1,517|(450)|
|Adjustments for:|||||
|Depreciation charges|214|225|214|225|
|Loss/(Gains) on investments|(659)|(1,363)|(659)|(1,363)|
|Investment income|(44)|(13)|(44)|(13)|
|(Increase)/Decrease in debtors|(392)|379|(487)|480|
|(Decrease)/Increase in creditors and|(291)|630|(239)|461|
|provisions|||||
|**Net cash provided by (used in)**|213|(557)|302|(660)|
|**operating activities**|||||



## 

## 

||**2024**|**2023**|
|---|---|---|
||**£'000**|**£'000**|
|Amounts due:|||
|Within 1 year|2|2|
|Within 2–4 years|5|7|





## 



## 



|**Principal place of business**|St Andrew’s House|
|---|---|
||48 Princess Road East|
||Leicester|
||LE1 7DR|
|**Statutory auditor**|Forvis Mazars LLP|
||Two Chamberlain Square|
||Birmingham|
||B3 3AX|
|**Principal banker**|The Royal Bank of Scotland plc|
||5 Market Street|
||Leicester|
||LE1 6DN|
|**Legal advisors**|Bates Wells Braithwaite LLP|
||10 Queens Street Place|
||London|
||EC4R 1BE|
||Nelsons|
||37 New Walk|
||Leicester|
||LE1 6TU|
|**Pension advisors**|Aegon|
||Platform Client Services|
||1-3 Lochside Crescent|
||Edinburgh Park|
||Edinburgh|
||EH12 9SE|
|**Investment managers**|CCLA|
||Senator House|
||85 Queen Victoria Street|
||London|
||EC4V 4ET|
|**Registered Charity**|229642|
|**Number**||
|**England and Wales**||
|**OSCR Charity Number**|SC039452|
|**Scotland**||